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In February and March 2012, excess deaths among the 
elderly have been observed in 12 European countries 
that carry out weekly monitoring of all-cause mortal-
ity. These preliminary data indicate that the impact of 
influenza in Europe differs from the recent pandemic 
and post-pandemic seasons. The current excess mor-
tality among the elderly may be related to the return of 
influenza A(H3N2) virus, potentially with added effects 
of a cold snap.
In	 most	 winter	 seasons,	 excess	 all-cause	 mortality	
among	the	elderly	is	observed	in	Europe.	The	extent	of	
this	 excess	 varies	 considerably	 between	 seasons	 and	
between	 countries	 [1-5].	 Most	 often,	 this	 excess	 has	
been	 attributed	 to	 seasonal	 influenza	 illness,	 espe-
cially	in	seasons	dominated	by	A(H3N2)	virus	subtype,	
but	other	 factors	 such	as	 cold	weather	and	 infections	
resulting	from	other	respiratory	agents	also	play	a	role	
[1-8].
Since	 the	 beginning	 of	 February	 2012,	 an	 increased	
number	of	excess	deaths	among	 the	elderly	has	been	
observed	 in	 a	 number	 of	 European	 countries	 that	
carry	 out	 weekly	 monitoring	 of	 all-cause	 age-specific	
mortality.
The	aim	of	this	article	 is	to	describe	the	occurrence	of	
this	 recently	observed	excess	mortality	 in	Europe	and	
consider	 potential	 explanations	 in	 order	 to	 encourage	
other	 countries	 to	 assess	 their	 situation	 and	 share	
experiences.
Monitoring all-cause mortality in Europe
Since	 autumn	 2009,	 monitoring	 of	 weekly	 all-cause	
mortality	 has	 been	 carried	 out	 in	 up	 to	 16	 countries	
across	 Europe.	 This	was	 initially	 part	 of	 the	 European	
monitoring	of	excess	mortality	for	public	health	action	
(EuroMOMO),	 a	 project	 funded	 first	 by	 the	 European	
Union	Health	Programme	 [9]	and	 later,	 European	mor-
tality	 monitoring	 received	 funding	 from	 the	 European	
Centre	for	Disease	Prevention	and	Control	 (ECDC).	The	
public	health	value	of	the	project	was	underlined	in	the	
2009	influenza	pandemic,	when	these	excess	mortality	
outputs	 became	 important	 for	 European	 risk	 assess-
ments	[10-12].
A	common	statistical	algorithm	is	used	in	EuroMOMO-
participating	 countries	 to	 generate	 weekly	 indicators	
for	age	group-specific	excess	mortality	that	are	compa-
rable	 across	 countries.	 The	 algorithm	 is	 a	 time-series	
Poisson	 regression	 model	 with	 number	 of	 weekly	
deaths	 as	 a	 dependent	 variable	 adjusting	 for	 trend	
and	seasonal	variation.	The	algorithm	also	corrects	for	
the	 delay	 observed	 between	 data	 collection	 and	 data	
processing	in	each	country.
The	main	indicators	generated	are:	
•	 total	weekly	number	of	deaths	corrected	for	delay	in	
registration;	
•	expected	weekly	number	of	deaths	(baseline);	
•	weekly	number	of	excess	deaths	(defined	as	observed	
number	minus	the	expected	number	of	deaths);	
•	standard	deviation	around	the	baseline	(z-score);	
•	 total	mortality	 (all	 age	 groups)	 and	mortality	 strati-
fied	into	age	groups	(<5,	5–14,	15–64	and	≥65	years).	
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Standard	deviation	scores	(z-scores)	are	used	to	stand-
ardise	 outputs	 and	 enable	 comparison	 of	 mortality	
patterns	 between	 different	 populations	 and	 between	
different	 time	 periods.	 Excess	 mortality	 above	 two	
z-scores	from	the	baseline	is	considered	above	the	nor-
mal	 level	 of	 the	 standard	 variation	 of	 data.	 Details	 of	
the	EuroMOMO	algorithm	can	be	found	elsewhere	[13].
Data	 outputs	 from	 individual	 partner	 countries	 are	
compiled	 by	 the	 Statens	 Serum	 Institut	 in	 Denmark.	
Data	analysed	for	this	paper	included	all-cause	mortal-
ity	from	week	1	(2	January)	up	to	and	including	week	11	
(18	March)	2012.	A	total	of	14	countries	submitted	data:	
Belgium,	Denmark,	 Finland,	 France,	Germany	 (Hessen	
region),	Greece	(regions	of	Athens,	Keratsini,	Magnisia	
and	 Kerkira),	 Hungary,	 Ireland,	 the	 Netherlands,	
Portugal,	 Spain,	 Sweden,	 Switzerland	 and	 the	 United	
Kingdom	(UK)	(England	and	Wales).
Data	on	influenza	activity	were	derived	from	the	ECDC	
weekly	 influenza	 surveillance	 overview	 [14],	 EuroFlu	
[15]	 and	 from	 personal	 communication	 with	 national	
influenza	surveillance	representatives.	Increased	influ-
enza	activity	was	defined	as	medium	or	high	influenza	
intensity,	as	reported	through	these	channels.
Results
All-cause	mortality	among	the	elderly	(individuals	aged	
≥65	years)	has	been	above	two	z-scores	from	the	base-
line	 for	 two	 consecutive	 weeks	 or	 more	 in	 Belgium,	
Portugal	 and	 Spain	 from	 week	 5,	 in	 France	 and	 the	
Netherlands	from	week	6,	in	Finland,	Hungary,	Sweden	
and	 Switzerland	 from	 week	 7.	 In	 the	 UK	 mortality	
among	the	elderly	has	been	above	2	z-scores	in	weeks	
7–8	 and	 11–12.	 Ireland	 reported	 a	 one-week	 peak	 of	
a	 z-score	 above	 2	 in	 week	 9	 and	 Greece	 in	 week	 10.	
Denmark	and	Germany	reported	no	excess	mortality.	
Although	 data	 from	 week	 11	 may	 be	 influenced	 by	
reporting	 delay,	 it	 appears	 that	mortality	 has	 peaked	
and	 is	 now	 decreasing	 in	 Belgium,	 Finland,	 France,	
Portugal,	Spain,	Sweden	and	the	Netherlands.
In	 Spain	 and	 Portugal,	mortality	 has	 been	 above	 two	
z-scores	 from	 the	 baseline	 for	 two	 and	 three	 weeks,	
respectively,	 in	 the	 age	 group	 15–64	 years	 of	 age.	
Otherwise,	there	has	been	no	sign	of	excess	mortality	
in	other	age	groups	studied	(0–4,	5–14	years).
In	 Portugal,	 Spain,	 France,	 Switzerland,	 Finland,	
Hungary,	 Ireland	 and	 Greece	 excess	 mortality	 among	
the	 elderly	 coincided	 with	 or	 followed	 after	 reported	
increased	 influenza	 activity	 (Figure	 2).	 In	 Belgium,	
Sweden	and	the	Netherlands,	excess	mortality	seemed	
to	precede,	at	least	partly,	reported	increased	influenza	
activity.	 In	 the	UK,	 there	was	 excess	mortality	 but	 no	
reported	 increased	 influenza	activity	and	 in	Germany,	
there	 was	 reported	 increased	 influenza	 activity	 but	
no	 excess	 mortality.	 Denmark,	 which	 has	 observed	
no	 excess	 mortality	 to	 date,	 reported	 no	 increased	
influenza	activity.	Among	 the	 countries	 that	observed	
excess	mortality,	 only	 the	 UK	 did	 not	 see	medium	 or	
high	 influenza	 activity	 at	 least	 in	 parts	 of	 the	 same	
time	period.
Discussion
As	 in	previous	winter	 seasons,	 a	 number	of	 European	
countries	 are	 experiencing	 increased	mortality	 in	 the	
elderly	 population.	 Unlike	 the	 past	 two	 seasons,	 the	
excess	 mortality	 this	 year	 coincided	 in	 most	 coun-
tries	with	 late	 increased	 influenza	 activity.	 An	 impact	
of	 influenza	 on	 the	 elderly	 is	 not	 unexpected,	 as	 this	
year	 is	 dominated	 by	 influenza	 A(H3N2):	 according	 to	
the	ECDC	weekly	influenza	surveillance	overview	of	30	
March	 2012,	 95%	 of	 the	 influenza	 A	 viruses	 detected	
from	 sentinel	 and	 non-sentinel	 sources	 this	 season	
were	 type	 H3N2	 [17].	 In	 contrast,	 influenza	 A(H1N1)
pdm09	was	 the	prevailing	 type	 in	 the	past	 two	years.	
The	 pandemic	 virus	 more	 or	 less	 spared	 the	 eld-
erly	 –	 although	 some	 countries,	 such	 as	 the	 UK,	 did	
observe	 excess	mortality	 in	middle-aged	 adults	 likely	
to	 be	 attributable	 to	 influenza	 A(H1N1)pdm09	 activity	
[4,10,18].	
There	 are,	 at	 present,	 differences	 in	 observed	 excess	
mortality	 between	 European	 countries	 using	 the	
EuroMOMO	algorithm.	The	available	influenza	data	do	
not	 offer	 an	 exhaustive	 explanation	 for	 these	 differ-
ences.	 In	 most	 countries,	 excess	 mortality	 coincided	
or	followed	after	reported	increases	in	influenza	activ-
ity.	 This	 pattern	 has	 been	 regularly	 observed	 in	 the	
pre-pandemic	years	[1-5,8]	and	corroborates	the	asso-
ciation	 of	 influenza	 (in	 particular	 influenza	 A(H3N2))	
and	 excess	 deaths	 in	 the	 elderly.	 In	 particular,	 in	 the	
present	 season	 there	 are	 reports	 that	 some	 of	 these	
influenza	A(H3N2)	viruses	are	an	imperfect	match	with	
the	A(H3N2)	strain	included	in	the	current	vaccine;	how-
ever,	the	contribution	of	this	to	the	epidemiology	of	the	
observed	excess	mortality	is	unclear	at	this	stage	[19].	
The	data	presented	 in	 Figure	2	 suggest	 that	 the	over-
lap	 between	 influenza	 activity	 and	 excess	 mortality	
was	 discordant	 in	 a	 few	 countries.	 There	 are	 several	
possible	explanations	for	this	observation.	Firstly,	 the	
different	patterns	may	suggest	 that	other	 factors	con-
tribute	 to	 the	 occurrence	 of	 excess	mortality.	 Indeed,	
there	 was	 a	 cold	 spell	 across	 Europe	 during	 weeks	 4	
to	6	 this	 year	 throughout	 Europe,	which	might	 add	 to	
excess	mortality	 in	some	countries,	but	not	 in	others.	
It	is	well	known	that	periods	of	extreme	cold	are	asso-
ciated	 with	 excess	 mortality	 [1,4,7,20,21].	 In	 Spain,	
Belgium	 and	 the	 Netherlands,	 excess	mortality	 could	
be	observed	before	 influenza	 transmission	 increased:	
we	hypothesise	 that	 the	 cold	 spell	 could	have	been	a	
contributing	factor	in	those	countries.			
Secondly,	 the	 current	 definition	 of	 increased	 national	
influenza	 activity	 is	 based	 on	 a	 risk	 assessment	 by	
each	 European	 country.	 As	 a	 consequence,	 there	 are	
subjective	 differences	 in	 how	 this	 is	 interpreted.	 This	
may	 also	 partially	 explain	 the	 apparent	 discordance	
between	observed	excess	mortality	and	reported	level	
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Figure 1
Weekly mortality among those aged ≥65 years in 14 EuroMOMO countries as standardised deviations from the baseline 
(z-scores), week 7 2009–week 11 2012 (9 Feb 2009–18 March 2012)
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of	 influenza	 activity	 seen	 in	 some	 counties.	 It	 high-
lights	the	importance	of	developing	more	standardised	
objective	 measures	 of	 influenza	 activity.	 Finally,	 it	 is	
possible	that	 infections	other	than	influenza	may	con-
tribute	 to	excess	mortality	among	 the	elderly	 in	some	
countries.	
The	occurrence	of	potential	risks	at	similar	times	–	i.e.	
the	 cold	 snap	 and	 increased	 influenza	 activity	 –	 this	
winter	 season	 highlights	 the	 difficulty	 of	 disentan-
gling	 the	effects	of	different	causes	of	excess	mortal-
ity.	 Studies	 have	 shown	 that	 multivariate	 regression	
models	can	be	successfully	used	to	better	quantify	the	
impact	 of	 mortality	 risks	 such	 as	 influenza	 viruses,	
other	 respiratory	 viruses	 as	 well	 as	 extreme	 weather	
conditions	[1,4,22,23].
In	 order	 to	 assess	 the	 public	 health	 impact	 of	 influ-
enza	at	the	population	level,	it	is	important	to	develop	
a	common	European	approach	to	estimate	the	number	
of	excess	deaths	associated	with	influenza.	By	includ-
ing	 relevant	 and	 standardised	 indicators	 of	 influenza	
activity,	 virological	 data,	 vaccination	 data,	 climatic	
data	 and	 other	 respiratory	 infection	 data,	 it	 will	 be	
possible	 to	 perform	 a	 timely	 regression	 analysis	 to	
estimate	 excess	 mortality	 associated	 with	 influenza.	
We	 recommend	 that	 a	 standard	 approach	 should	 be	
developed	with	 the	 results	 summarised	 at	 the	 end	 of	
the	 influenza	 season	 when	 final	 data	 are	 available.	
However,	 it	 is	 also	 important	 on	 an	 ongoing	 basis	 to	
collate,	 analyse,	 interpret	 and	 disseminate	 mortal-
ity	 data	 in	 order	 to	 inform	 public	 health	 actions.	 As	
cause-of-death	 in	most	countries	will	not	be	available	
in	a	timely	fashion,	this	has	to	be	carried	out	based	on	
all-cause	mortality	 data,	 and	has	 to	 be	 interpreted	 in	
a	qualitative	method	as	 in	 the	present	paper.	 	On	 the	
basis	of	our	preliminary	data,	we	hypothesise	that	the	
epidemiology	of	 the	 impact	of	 influenza	 in	Europe	dif-
fers	 in	 the	 2011/12	 season	 from	 the	 recent	 pandemic	
and	 post-pandemic	 seasons,	 with	 excess	mortality	 in	
the	 elderly	 caused	by	 the	 return	 of	 influenza	A(H3N2)	
virus,	potentially	with	the	added	effects	of	a	cold	snap.
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